Summit Therapeutics Inc.

Historical 13F Holders

Symbol
SMMT
CUSIP
86627R102
All holders as of
Q1 2025
Type
Equity
Class
SPONS ADS
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 10 2.32 k $44.4 k
2024 Q4 7 11.4 k $204 k
2024 Q3 2 885 $19.4 k
2024 Q2 2 866 $6.76 k
2024 Q1 2 548 $2.27 k
2023 Q4 2 11.5 k $30.0 k
2023 Q3 2 11.7 k $22.0 k
2023 Q2 4 47.9 k $120 k
2023 Q1 6 52.0 k $91.0 k
2022 Q4 4 5.53 k $23.5 k
2022 Q3 3 16.2 k $19.0 k
2022 Q2 4 14.5 k $14.0 k
2022 Q1 5 14.3 k $34.0 k
2021 Q4 3 11.4 k $30.0 k
2021 Q3 3 11.9 k $59.0 k
2021 Q2 4 13.0 k $96.0 k
2021 Q1 3 11.7 k $68.0 k
2020 Q4 5 62.7 k $295 k
2020 Q3 3 68.6 k $235 k
2020 Q2 22 8.19 M $24.3 M
2020 Q1 12 8.40 M $19.9 M
2019 Q4 14 2.74 M $4.39 M
2019 Q3 15 2.66 M $4.76 M
2019 Q2 12 2.66 M $3.37 M
2019 Q1 16 2.60 M $4.75 M
2018 Q4 14 2.88 M $3.32 M
2018 Q3 15 2.95 M $6.54 M
2018 Q2 18 3.47 M $8.51 M
2018 Q1 21 4.20 M $54.1 M
2017 Q4 21 4.02 M $44.5 M
2017 Q3 21 4.05 M $50.9 M
2017 Q2 14 2.69 M $30.5 M
2017 Q1 16 2.70 M $35.9 M
2016 Q4 12 2.70 M $23.1 M
2016 Q3 13 2.73 M $24.8 M
2016 Q2 11 2.73 M $21.9 M
2016 Q1 10 2.67 M $18.3 M
2015 Q4 11 2.84 M $32.6 M
2015 Q3 11 2.84 M $29.5 M
2015 Q2 11 2.79 M $29.6 M
2015 Q1 8 2.68 M $33.2 M